Notice Title

Consent to the Distribution of New Medicines

Publication Date
22 Nov 2018

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2018-go5860
Title
View PDF
File Type and Size
PDF (28 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Keytruda
Pembrolizumab 25mg/mL
Concentrate for infusion
Merck Sharp & Dohme (New Zealand) Limited
MSD International GmbH (Ireland), Carlow, Ireland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Keytruda
Pembrolizumab 50mg
Powder for infusion
Merck Sharp & Dohme (New Zealand) Limited
MSD International GmbH, Innishannon, Ireland

Dated this 16th day of November 2018.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).